Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Oncovision

Explore full profile

Leading provider of innovative medical imaging devices

Valencia, SpainFounded 2003Biotech & Life Sciences
Valuation $5–10M Last recorded · 2022
Revenue $1–10M Latest reported FY
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Oncovision and the history behind them.

About Oncovision

Oncovision is a leading player in the innovative medical imaging market, with a focus on early cancer diagnosis. The company's primary mission is to improve the quality of life for patients and enhance the experience of healthcare professionals. They achieve this by developing advanced molecular imaging techniques that set a new standard for cancer diagnosis and treatment.

Oncovision's clients are primarily healthcare professionals and institutions that require advanced diagnostic tools for cancer detection. The company operates in the global medical imaging market, a sector that is witnessing significant growth due to the increasing prevalence of chronic diseases and advancements in imaging technologies.

The business model of Oncovision is centered around the development and sale of their innovative imaging solutions. They generate revenue by selling these advanced diagnostic tools to healthcare institutions. Additionally, Oncovision also provides specific services requested by the subscriber or user, which contributes to their revenue stream.

The company's core values of innovation, commitment, excellence, and continuous improvement are reflected in their cutting-edge products and services. Oncovision also places a high emphasis on data privacy and security, ensuring that any information stored or accessed is used strictly for legitimate purposes and cannot be used to identify individuals without proper authorization.

In summary, Oncovision is a pioneering company in the medical imaging market, providing innovative solutions for early cancer diagnosis and treatment. Their commitment to improving patient care and healthcare professionals' experience, coupled with their robust revenue model, positions them as a strong player in the healthcare sector.

Source: Dealroom company data

At a glance

Founded
2003
Headquarters
Valencia, Spain
Sector
Biotech & Life Sciences

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed6 investors entered at this stage

  • Bullnet Capital
  • CRB Inverbío
  • AXIS
  • European Innovation Council
  • European Commission
  • CDTI Innvierte
Team profiled 5 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇪🇸 Spain100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Oncovision on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Oncovision on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.